alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease).
作者信息
HERS H G
出版信息
Biochem J. 1963 Jan;86(1):11-6. doi: 10.1042/bj0860011.
Abstract
摘要
相似文献
1
alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease).
Biochem J. 1963 Jan;86(1):11-6. doi: 10.1042/bj0860011.
2
Biosynthesis of acid alpha-glucosidase in late-onset forms of glycogenosis type II (Pompe's disease).
FEBS Lett. 1982 Dec 13;150(1):69-76. doi: 10.1016/0014-5793(82)81306-9.
3
DIAGNOSIS OF GENERALIZED GLYCOGEN STORAGE DISEASE (POMPE'S DISEASE).
J Pediatr. 1963 Nov;63:984-7. doi: 10.1016/s0022-3476(63)80230-9.
4
Prenatal diagnosis of glycogenosis type II (Pompe's disease) using chorionic villi biopsy.
Clin Genet. 1985 May;27(5):479-82. doi: 10.1111/j.1399-0004.1985.tb00235.x.
5
Properties of the alpha-glucosidase from various human tissues in relation to glycogenosis type II (Pompe's disease).
Clin Chim Acta. 1977 Aug 1;78(3):473-8. doi: 10.1016/0009-8981(77)90080-8.
6
Use of immobilized antibodies in investigating acid alpha-glucosidase in urine in relation to Pompe's disease.
Biochim Biophys Acta. 1979 Apr 12;567(2):370-83. doi: 10.1016/0005-2744(79)90123-2.
7
Angiocardiographic and enzyme studies in a patient with type II glycogenosis (Pompe's disease). A case report.
S Afr Med J. 1980 Nov 22;58(21):860-2.
8
Physico-chemical and immunological properties of acid alpha-glucosidase from various human tissues in relation to glycogenosis type II (Pompe's disease).
Clin Chim Acta. 1976 Apr 1;68(1):49-58. doi: 10.1016/0009-8981(76)90287-4.
9
alpha-Glucosidase in Pompe's disease.
J Inherit Metab Dis. 1978;1(4):153-4. doi: 10.1007/BF01805584.
10
Lysosomal glycogen storage mimicking the cytological picture of Pompe's disease as induced in rats by injection of an alpha-glucosidase inhibitor. I. Alterations in liver.
Virchows Arch B Cell Pathol Incl Mol Pathol. 1981;38(1):89-100. doi: 10.1007/BF02892805.
引用本文的文献
1
Expert opinion on clinical presentation, diagnosis, and treatment of infantile-onset Pompe disease: a Delphi study in Türkiye.
Turk J Med Sci. 2024 Nov 20;55(3):585-594. doi: 10.55730/1300-0144.6005. eCollection 2025.
2
Diaphragm Muscle: A Pump That Can Not Fail.
Physiol Rev. 2025 Jul 11. doi: 10.1152/physrev.00043.2024.
3
Unexplained Progressive Respiratory Insufficiency and Weakness Diagnosed as Late-Onset Pompe Disease Through Biochemical and Molecular Genetic Testing.
Neurohospitalist. 2025 Jun 5:19418744251348055. doi: 10.1177/19418744251348055.
4
Cardiovascular involvement in glycogen storage diseases.
Nat Rev Cardiol. 2025 Jun 5. doi: 10.1038/s41569-025-01171-w.
5
Management of Pompe disease alongside and beyond ERT: a narrative review.
Acta Myol. 2025 Mar;44(1):11-22. doi: 10.36185/2532-1900-1106.
6
Dose-intensive therapy (DIT) for infantile Pompe disease: A pilot study.
Mol Genet Metab Rep. 2024 Dec 17;42:101179. doi: 10.1016/j.ymgmr.2024.101179. eCollection 2025 Mar.
7
Predicting the phenotype of Pompe Disease from features of GAA variants.
Eur J Hum Genet. 2025 May;33(5):688-691. doi: 10.1038/s41431-024-01771-z. Epub 2025 Jan 7.
8
Mechanisms and Therapeutic Strategies for Myocardial Ischemia-Reperfusion Injury in Diabetic States.
ACS Pharmacol Transl Sci. 2024 Nov 1;7(12):3691-3717. doi: 10.1021/acsptsci.4c00272. eCollection 2024 Dec 13.
9
Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease.
J Patient Rep Outcomes. 2024 Nov 13;8(1):132. doi: 10.1186/s41687-024-00805-w.
10
Pharmacological modulation of respiratory control: Ampakines as a therapeutic strategy.
Pharmacol Ther. 2025 Jan;265:108744. doi: 10.1016/j.pharmthera.2024.108744. Epub 2024 Nov 8.
本文引用的文献
1
Glycogen storage disease of the heart. II. Critical review of the literature.
Pediatrics. 1950 Oct;6(4):607-24.
2
Synthesis of oligosaccharides from maltose by rat liver.
Science. 1955 Jun 24;121(3156):898.
3
Cytoplasmic components in hepatic cell lysosomes.
J Cell Biol. 1962 Jan;12(1):198-202. doi: 10.1083/jcb.12.1.198.
4
The mechanism of carbohydrase action. 8. Structures of the muscle-phosphorylase limit dextrins of glycogen and amylopectin.
Biochem J. 1960 Aug;76(2):264-8. doi: 10.1042/bj0760264.
5
A glucose oxidase reagent for maltase assay.
Anal Biochem. 1961 Aug;2:380-4. doi: 10.1016/0003-2697(61)90011-2.
6
Glucose production by isolated rat liver cells. An amylase-oligoglucosidase pathway for glycogen breakdown.
J Biol Chem. 1961 May;236:1247-52.
7
Liver amylase. II. Physiological role.
J Biol Chem. 1961 May;236:1259-63.
8
Determination of maltase and isomaltase activities with a glucose-oxidase reagent.
Biochem J. 1961 Sep;80(3):547-51. doi: 10.1042/bj0800547.
9
Equilibrium constants of phosphoryl transfer from C-1 to C-6 of alpha-D-glucose 1-phosphate and from glucose 6-phosphate to water.
Biochem J. 1961 Apr;79(1):12-5. doi: 10.1042/bj0790012.
10
Glycogen storage disease of the heart; clinical observations in five infants.
J Pediatr. 1958 Jun;52(6):635-48. doi: 10.1016/s0022-3476(58)80262-0.
Zotero 插件